All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
| Mon 1984-11-05? to Fri 2024-07-26 |
YTD
Return |
TR
Price |
||||
|---|---|---|---|---|---|---|
| GSK × |
+9.51%
2024-07-26 |
45.99 TR
2024-07-26 |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
| Mon 1984-11-05? to Fri 2024-07-26 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| GSK × |
+4,499.05%
+10.12%/yr |
+7.68%/yr
(R2=0.817) |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
| Mon 1984-11-05? to Fri 2024-07-26 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| GSK × |
$10,000.00
1984-11-05 |
$459,905.39
2024-07-26 |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
| Year | GSK |
|---|---|
| 2024 (YTD) | +9.51% |
| 2023 | +9.72% |
| 2022 | −18.32% |
| 2021 | +26.65% |
| 2020 | −17.75% |
| 2019 | +29.22% |
| 2018 | +13.66% |
| 2017 | −3.00% |
| 2016 | +1.82% |
| 2015 | −0.38% |
| 2014 | −15.70% |
| 2013 | +28.90% |
| 2012 | +0.63% |
| 2011 | +22.55% |
| 2010 | −2.16% |
| 2009 | +19.29% |
| 2008 | −22.29% |
| 2007 | −0.81% |
| 2006 | +7.91% |
| 2005 | +9.85% |
| 2004 | +5.58% |
| 2003 | +28.47% |
| 2002 | −22.78% |
| 2001 | −9.78% |
| 2000 | +3.58% |
| 1999 | −17.89% |
| 1998 | +48.21% |
| 1997 | +54.80% |
| 1996 | +17.10% |
| 1995 | +44.33% |
| 1994 | +2.27% |
| 1993 | −8.91% |
| 1992 | −23.55% |
| 1991 | +93.89% |
| 1990 | +25.96% |
| 1989 | +35.07% |
| 1988 | +5.48% |
| 1987 | +18.22% |
| 1986 | +39.15% |
| 1985 | +74.89% |
| 1984 | −1.94% |
| Mon 1984-11-05? to Fri 2024-07-26 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| GSK × | −12.93% |
−55.72%
1993-08-13 |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||